[Molecular phenotypes of breast cancer and their clinical application].
Tang
Ping
P
Department of Pathology, University of Rochester Medical Center, Rochester, New York 14642, USA. ping_tang@urmc.rochester.edu
Wei
Bing
B
Hicks
David G
DG
Skinner
Kristin
K
Bu
Hong
H
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism / Q000473:pathology*; D016207:Cytokines / Q000378:metabolism; D016503:Drug Delivery Systems; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D007150:Immunohistochemistry; D016130:Immunophenotyping; D010641:Phenotype; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D016207:Cytokines; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C508053:ERBB2 protein, human